ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,286Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 298

$687K Total Retail Price of All Prescriptions

Rank: 8 out of 298

486 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 486 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 486 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 12,733 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 871 805 1 1
METOPROLOL TARTRATE 539 507 2 9
AMLODIPINE BESYLATE 522 505 3 6
OMEPRAZOLE 486 453 4 3
FUROSEMIDE 437 397 5 5
LISINOPRIL 383 340 6 4
POTASSIUM CHLORIDE 319 299 7 11
ALENDRONATE SODIUM 272 239 8 21
WARFARIN SODIUM 258 249 9 7
FENTANYL 240 233 S2 10 32
HYDROCODONE-ACETAMINOPHEN 213 187 S3 11 8
PRAVASTATIN SODIUM 207 183 12 31
LOSARTAN POTASSIUM 194 186 13 18
ATENOLOL 191 189 14 16
METOPROLOL SUCCINATE 188 149 15 12
POLYETHYLENE GLYCOL 3350 185 161 16 29
SIMVASTATIN 184 184 17 2
CITALOPRAM HBR 178 153 18 17
GABAPENTIN 176 159 19 20
ALBUTEROL SULFATE 163 163 20 75
MIRTAZAPINE 158 158 21 37
CRESTOR 149 128 22 26
DONEPEZIL HCL 137 119 23 22
NAMENDA 136 134 24 35
GLIMEPIRIDE 133 98 25 60
METFORMIN HCL 128 95 26 10
ADVAIR DISKUS 127 117 27 46
ATORVASTATIN CALCIUM 126 113 28 14
TORSEMIDE 125 125 29 110
TRAMADOL HCL 125 108 29 15
DIOVAN 116 109 31 47
MELOXICAM 112 101 32 41
GEMFIBROZIL 106 92 33 65
LANTUS 104 97 34 53
TAMSULOSIN HCL 95 93 35 24
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 89 36 118
HYDROCHLOROTHIAZIDE 94 81 36 13
LEVOFLOXACIN 93 84 38 101
CEFDINIR 92 81 39 174
ISOSORBIDE MONONITRATE ER 89 80 40 45
KLOR-CON M10 88 88 41 180
SPIRIVA 78 64 42 55
TRAMADOL HCL-ACETAMINOPHEN 76 75 43 129
TRAZODONE HCL 75 62 44 39
NOVOLOG 74 66 45 102
SERTRALINE HCL 72 66 46 19
ZOLPIDEM TARTRATE 72 57 46 25
AMLODIPINE BESYLATE-BENAZEPRIL 72 72 46 98
DIGOXIN 71 71 49 27
LABETALOL HCL 69 69 50 87
KLOR-CON 10 67 59 51 61
RISPERIDONE 64 61 52 54
CLOPIDOGREL 63 56 53 36
AMOX TR-POTASSIUM CLAVULANATE 63 50 53 154
CARVEDILOL 62 62 55 23
GENERLAC 60 55 56 143
NIFEDIPINE ER 60 60 56 130
FLUTICASONE PROPIONATE 60 54 56 38
OXYBUTYNIN CHLORIDE 58 15 59 81
TRIAMTERENE-HCTZ 58 58 59 43
GLIPIZIDE 57 57 61 69
QUETIAPINE FUMARATE 56 46 62 68
SYNTHROID 55 47 63 42
ENULOSE 55 47 63 227
IPRATROPIUM BROMIDE 53 53 65 107
SUCRALFATE 52 41 66 104
OLANZAPINE 52 52 66 142
CARBIDOPA-LEVODOPA 52 52 66 49
FLUCONAZOLE 51 44 69 197
NEXIUM 50 44 70 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.